Monitoring of endothelial leucocyte adhesion molecule-1 in anti-neutrophil-cytoplasmic-antibody-positive vasculitis.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  American Journal of Nephrology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000168980PMID 8919225
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Autoantibodies to lactoferrin and histone in systemic vasculitis identified by anti-myeloperoxidase solid phase assays.

  1994cited by this paper
• Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis.

  1993cited by this paper
• Serum ELAM-1 is increased in vasculitis, scleroderma, and systemic lupus erythematosus.

  1993cited by this paper
• Relationship between markers of endothelial dysfunction, oxidant injury and tubular damage in patients with insulin-dependent diabetes mellitus.

  1993cited by this paper
• Fundamental and clinical aspects of anti neutrophil cytoplasmic antibodies (ANCA).

  1992cited by this paper
• Endothelial-leukocyte adhesion molecule 1 stimulates the adhesive activity of leukocyte integrin CR3 (CD11b/CD18, Mac-1, alpha m beta 2) on human neutrophils

  1991cited by this paper
• Wegener's autoantigen decoded

  1990cited by this paper
• Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme

  1990cited by this paper
• An ELISA for the detection of anti-neutrophil cytoplasm antibodies (ANCA).

  1990cited by this paper
• Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro.

  1990cited by this paper
• Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre.

  1990cited by this paper
• Association between active Wegener's granulomatosis and anticytoplasmic antibodies.

  1989cited by this paper
• Infectious complications of cyclophosphamide treatment for vasculitis.

  1989cited by this paper
• Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins.

  1989cited by this paper
• Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase.

  1989cited by this paper
• Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis.

  1988cited by this paper
• Cyclophosphamide-induced bladder toxicity in Wegener's granulomatosis.

  1988cited by this paper
• Factor VIII related antigen in the assessment of vasculitis.

  1987cited by this paper
• Vascular damage and factor-VIII-related antigen in the rheumatic diseases

  1987cited by this paper
• The spectrum of diseases associated with necrotizing glomerulonephritis and its prognosis.

  1985cited by this paper
• Renal vasculitis.

  1985cited by this paper
• Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis.

  1985cited by this paper
• Objective monitoring of disease activity in polyarteritis by measurement of serum C reactive protein concentration.

  1984cited by this paper
• Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years.

  1983cited by this paper
• Synthesis and Release of Factor VIII by Cultured Human Endothelial Cells

  1981cited by this paper
• Factor VIII-Related Activities in Normal, Haemophilic and von Willebrand’s Disease Platelet Fractions

  1978cited by this paper
• Factor VIII and renal disease.

  1977cited by this paper

• Successful Treatment of Recurrent Wegener's Granulomatosis in a Transplanted Kidney with Rituximab, Plasmapheresis, and Steroids

  2009cites this paper
• Immunopathology of Pulmonary Vasculitides

  2008cites this paper
• Serial ANCA determinations for monitoring disease activity in patients with ANCA-associated vasculitis: systematic review.

  2006cites this paper
• Circulating levels of soluble adhesion molecules in patients with ANCA-associated vasculitis.

  2004cites this paper
• Assessing disease activity in the systemic vasculitides

  2002cites this paper
• Recurrence of Wegener's granulomatosis 13 years after renal transplantation.

  2001cites this paper
• A genetically determined high setting of TNF-alpha influences immunologic parameters of HLA-B8,DR3 positive subjects: implications for autoimmunity.

  2001cites this paper
• Leukocyte Cell Adhesion Molecules in Vasculitis

  2001cites this paper
• Prominence of cell-mediated immunity effectors in "pauci-immune" glomerulonephritis.

  1999cites this paper
• Evaluación de la actividad de las vasculitis

  1998cites this paper
• 9 Laboratory findings in the vasculitides

  1997cites this paper
• Laboratory findings in the vasculitides.

  1997cites this paper